Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC - 2024-04-25T10:32:28.000Z

The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.

In related news

Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.
- Related Articles
- In News
- From CNBC
- 2024-05-01T11:13:54.000Z
Coca-Cola Raises Prices, Earnings Beat Expectations
00:00Let's start with McDonald's. An interesting reaction there when it comes to comparable sales growth. There was just 1.9% that was...
- Related Articles
- In News
- From Bloomberg.com
- 2024-04-30T15:08:32.862Z
Eli Lilly Jumps On Strong Earnings, Guidance As Zepbound Sales Beat
Eli Lilly (LLY) jumped early Tuesday after the pharma behemoth reported adjusted earnings of $2.58 per share on $8.77 billion in...
- Related Articles
- In News
- From Investor's Business Daily
- 2024-04-30T11:44:17.000Z